Mechanism of epigenetic-driven inactivation of tumor suppressor SIGIRR

2015/19/B/NZ6/01578

Keywords

Descriptors

  • NZ6_2: Immunologia kliniczna
  • NZ5_3: Patogeneza chorób człowieka
  • NZ2_2: Genomika, transkryptomika i epigenomika

Panel

NZ6 – Human and animal immunology and infection: immunity, immune disorders, immunotherapy, infectious and invasive diseases, microbiology, transplantology, allergology

Host institution

Uniwersytet Jagielloński, Wydział Biochemii, Biofizyki i Biotechnologii

Voivodeship: małopolskie

Other projects carried out by the institution »

Principal investigator (from the host institution)

dr Katarzyna Bulek

Number of co-investigators in the project: 5

Call

OPUS 10 – announced on 2015-09-15

Amount awarded
2 000 000 PLN
Project start date
2016-10-03
Project end date
2022-04-02
Project duration
66 months (the same as in the proposal)
Project status
Project settled

Project description

Download the project description in a pdf file

Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.

Equipment purchased [PL]

  1. Komputer stacjonarny. Cost: 6 000 PLN
  2. Pompa perystaltyczna. Cost: 6 361 PLN
  3. Seahorse XFp Extracellular Flux Analyzer. Cost: 260 000 PLN
  4. licznik komórek. Cost: 19 998 PLN
  5. zestaw do elektroforezy. Cost: 9 243 PLN

Information in the final report

Publication in academic press/journals (3)

  1. Epithelial-derived gasdermin D mediates nonlytic IL-1β release during experimental colitis

    Authors:
    Bulek K, Zhao J, Liao Y, Rana N, Corridoni D, Antanaviciute A, Chen X, Wang H, Qian W, Miller-Little WA, Swaidani S, Tang F, Willard BB, McCrae K, Kang Z, Dubyak GR, Cominelli F, Simmons A, Pizarro TT, Li X.
    Academic press:
    The Journal of Clinical Investigation (year: 2020, volume: 130(8), pages: 4218–4234), Publisher: The American Society for Clinical Investigation
    Status:
    Published
    DOI:
    10.1172/JCI138103 – link to the publication
  2. The Ras GTPase-activating-like protein IQGAP1 bridges Gasdermin D to the ESCRT system to promote IL-1β release via exosomes

    Authors:
    Liao Y*, Chen X, Miller-Little W, Wang H, Willard B, Bulek K*, Zhao J*, Li X*, *corresponding author
    Academic press:
    The EMBO Journal (year: 2022, volume: 46340, pages: e110780), Publisher: EMBO press
    Status:
    Published
    DOI:
    10.15252/embj.2022110780 – link to the publication
  3. Dominant-Negative Form of SIGIRR: SIGIRRΔE8 Promotes Tumor Growth Through Regulation of Metabolic Pathways

    Authors:
    Bodaszewska-Lubas M, Liao Y, Zegar A, Szelest O, Dobrucki J, Bulek K*, *corresponding author
    Academic press:
    Journal of Interferon & Cytokine Research (year: 2022, volume: 42(9), pages: 482-492), Publisher: Mary Ann Liebert, Inc
    Status:
    Published
    DOI:
    10.1089/jir.2022.0095 – link to the publication

« New search

Graphic design and implementation: Jakub Piotrowski